XML 31 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jan. 31, 2021
Apr. 30, 2020
Current Assets:    
Cash and cash equivalents $ 5,563 $ 4,365
Restricted cash 540 850
Receivables, less allowance; $669; $606, on each respective date 30,091 28,062
Inventories 15,615 15,330
Income tax receivable 4,205 2,717
Prepaid expenses and other current assets 4,109 2,907
Total Current Assets 60,123 54,231
Property, plant and equipment, at cost 59,640 57,859
Accumulated depreciation (43,429) (41,587)
Net Property, Plant and Equipment 16,211 16,272
Right of use assets 9,715 9,312
Deferred income taxes 0 336
Other assets 3,560 3,778
Total Assets 89,609 83,929
Current Liabilities:    
Short-term borrowings 4,493 4,719
Current portion of capital lease liability 21 19
Current portion of operating lease liabilities 1,352 1,282
Accounts payable 15,996 13,114
Employee compensation and amounts withheld 4,546 4,159
Deferred revenue 3,642 2,508
Other accrued expenses 1,563 1,259
Total Current Liabilities 31,613 27,060
Long-term portion of capital lease liability 97 113
Long-term portion of operating lease liabilities 8,276 7,780
Accrued pension and deferred compensation costs 10,298 9,303
Deferred income taxes 225 401
Other non-current liabilities 838 569
Total Liabilities 51,347 45,226
Commitments and Contingencies
Stockholders’ Equity:    
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,766 shares; 2,754 shares; – Outstanding – 2,763 shares; 2,751 shares, on each respective date 6,915 6,885
Additional paid-in-capital 3,684 3,360
Retained earnings 37,124 37,821
Accumulated other comprehensive loss (9,615) (9,598)
Common stock in treasury, at cost, 3 shares, on each date (53) (53)
Total Kewaunee Scientific Corporation Stockholders’ Equity 38,055 38,415
Noncontrolling interest 207 288
Total Stockholders’ Equity 38,262 38,703
Total Liabilities and Stockholders’ Equity $ 89,609 $ 83,929